|
|
DSpace at RU >
Browsing by Author Vos, W.
Showing results 1 to 5 of 5
| Full Text | Issue Date | Title | Author(s) | | 2008 | Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas. | Galen, J.C. van; Muris, J.J.; Giroth, C.P.; Vos, W.; Ossenkoppele, G.J., et al |
| 2007 | Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation. | Houdt, I.S. van; Muris, J.J.; Hesselink, A.T.; Kramer, D.; Cillessen, S.A., et al |
| 2006 | Die Grenze in den Niederlanden | Enckevort, H.L. van; Hazenberg, T.; Vos, W.; Graafstal, E.; Polak, M. |
| 2006 | Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. | Muris, J.J.; Meijer, C.J.M.; Vos, W.; Krieken, J.H.J.M. van; Jiwa, N.M., et al |
| 2005 | Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas. | Muris, J.J.; Cillessen, S.A.; Vos, W.; Houdt, I.S. van; Kummer, J.A., et al |
Showing results 1 to 5 of 5
|